Crown Bioscience Inc.

Are you interested in evaluating your immunotherapy and immune modulating compounds? If so, we can help you with this assessment using syngeneic and/or tumor homograft model panels. Click on the link below to choose models that fit your needs and to enroll your study today https://bit.ly/3rEItP9... #PreclinicalResearch #CrownBio

Don't forget, tomorrow is our webinar - "Leveraging 3D In Vitro Models for Oncology Drug Discovery" There is still time to register, visit: https://bit.ly/3paYSu0 #drugdiscovery #invitromodels

Last month we launched our new Mouse Immunooncology RNA-Seq Panel. If you want to learn about our expertise in murine I/O studies, follow the link below, where you can also download our gene list. https://bit.ly/2LS41sj #RNASeq #immunooncology #CrownBio

Have you registered to join Ying Chih Chang, Academia Sinica, Taiwan, and others, at our symposium in Taiwan this week? Secure your seat now by following the link below to hear her talk on Single Cell Derived Organoids Toward Precision Medicine. We will also be discussing the potential of #TumorOrganoids and other patient-relevant 3D models in oncology drug development. https://bit.ly/39AtOhG... #3D https://bit.ly/39AtOhG

Wishing all of our customers, friends and colleagues a very Happy Chinese New Year. #YearoftheOx

Join Dr Yinfei Yin on October 30th to learn more about unique imaging models, including engineered models and tumor homografts https://bit.ly/3kkgLUA

Don't miss Dr Nicole Niu presenting at the Biomarkers Series US: Virtual event today, at 3pm PDT. Nicole will be sharing our translational oncology expertise, how pharmaceutical and diagnostic companies can partner in CDx development, and a range of case studies on biomarker and CDx discovery, validation, and commercialization https://bit.ly/33PR3QL

New blog post! Explore how transgenic diphtheria toxin receptor (DTR) models are used to better understand immunotherapy mechanisms of action and response https://bit.ly/3762My4

Sign up now for our new webinar to explore the value optical imaging brings to preclinical oncology research, with an emphasis on immunotherapy development https://bit.ly/3iShVF9

Join Dr Ludovic Bourré this Wednesday to learn more about the cutting edge organoid and in vivo models available for CAR-T cell therapy evaluation. During our interactive Lunch and Learn event, you’ll also have the chance to ask any questions related to your preclinical CAR-T cell studies

We're delighted to announce the appointment of Pam Shang as our new VP of Global Quality. Pam brings a deep expertise in implementing quality systems across pharma and biotechnology companies, and will be instrumental in further enhancing global quality across CrownBio https://bwnews.pr/2SCGj34

Review the Q&A from our recent next generation syngeneic models webinar, answered by Dr Davy Ouyang, Vice President of Scientific Research & Innovation https://bit.ly/33nMDBB

We provide a wide range of preclinical solutions, but did you know we can also help you in the translational space? Read our new publication on the genomic analysis of clinical patient samples which can help guide patient stratification https://bit.ly/3cGSCET

Join us at the Biomarkers Series US: Virtual event later this month. We'll be presenting on our integrated platform for biomarker and companion diagnostic development, and you can also head over to our booth to meet the team and download a range of posters and product information https://bit.ly/3kF0tFG

Register now for our upcoming virtual Lunch and Learn Seminar to explore patient-derived organoid and xenograft models as translational platforms for preclinical CAR-T cell therapy evaluation https://bit.ly/2FzvWKu

If you missed our syngeneic model webinar last week, it's now on our website to watch on demand. This in depth presentation features the latest in syngeneic model research, including deep kinetic profiling, immune cell depletion studies, as well as next generation syngeneics such as engineered and bioluminescent models https://bit.ly/30dASvC

Don't miss our webinar tomorrow! Join Dr Fred Beasley to explore how to choose the right rodent obesity model based on study aims and a thorough understanding of current and next-gen model advantages and limitations https://bit.ly/2Cdnjn6

Read the thoughts of Dr Jim Wang and Dr Astrid Doerner on targeting autoimmunity rather than hyperglycemia for type 1 diabetes, in the new DDNews special report https://bit.ly/36f1rV4